Physicians Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will conduct the CME-Certified satellite symposium Improving Outcomes in Progressive Fibrosing-Interstitial Lung Disease (PF-ILD) Through Early and Accurate Diagnosis, adjunct to the 2019 American Roentgen Ray Society (ARRS) Annual Meeting. The live program will take place Thursday, May 9, from 11:30 a.m. to 12:30 p.m. at the Hawaii Convention Center in Honolulu.
The educational program will be chaired by Dr. Joshua J. Solomon, associate chief in the section of critical care and associate professor of medicine in the division of pulmonary, critical care and sleep medicine at National Jewish Health in Denver.
We look forward to presenting this program at this years ARRS Annual Meeting, said Phil Talamo, president of PER. Progressive fibrosing-interstitial lung disease is a serious pulmonary disorder, and it is very important that clinicians are up to date on improving the diagnosis of the disease in effort to improve patient management and optimizing overall outcomes.
This interactive symposium will consist of three case-based discussions specifically designed to inform radiologists on early recognition, differential and accurate diagnosis, as well as new and emerging treatments for patients with PF-ILDs. Radiologists who attend will be able to improve their ability to diagnose and differentiate PF-ILD earlier in the course of disease, allowing more prompt intervention; identify key mechanisms underlying the various forms, clinical presentation, and management of PF-ILD; interpret radiographic patterns on high-resolution computed tomography to differentially diagnose ILDs, including idiopathic PF; and discuss current and emerging treatments for managing the various forms of PF-ILD and their potential use in clinical practice.
For more information and to register, click here.
About Physicians Education Resource
Since 1995, PER has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER initiated CME programming in the cardiovascular and endocrinology areas and continues to grow its therapeutic reach outside oncology. While continuing to expand into topics outside of oncology, PER remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER is part of the Cranbury, New Jersey-based MJH Associates, Inc., family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.
PER® Media Contacts
Alexandra Ventura, 609-716-7777,
John Patricolo, 609-325-4630